Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: von Tempelhoff, Georg‐Friedrich; | Schönmann, Nicole | Heilmann, Lothar | Pollow, Kunhard | Hommel, Gerhard
Affiliations: Department of Obstetrics and Gynecology, City Hospital of Ruesselsheim, August‐Bebel Strasse 59, 65428 Ruesselsheim, Germany | Experimental Endocrinology, University of Mainz, Germany | Institute for Medical Statistics and Documentation, University of Mainz, Obere Zahlbachstrasse 69, 55131 Mainz, Germany
Note: [] Corresponding author: Dr. Georg‐Friedrich von Tempelhoff, MD, Dept. Obstet. Gynecol., City Hospital of Ruesselsheim, August‐Bebel Strasse 59, 65428 Ruesselsheim, Germany. Tel.: +49 6142 881316; Fax: +49 6142 61114; E‐mail: G‐F.von.Tempelhoff@t‐online.de.
Abstract: Tumor growth leads to tissue hypoxia and tissue hypoxia, in turn, is a strong stimulus for expression of genes encoding factors that promote tumor growth. Likewise, hypoxia is a key condition within the vicious cycle of autogenous neoplastic dissemination. A marker of the presence of tissue hypoxia may be the presence of high blood viscosity, which is found in a number of neoplastic diseases including gynecological cancer. At the time of diagnosis of breast cancer, patients dying of this disease had had significantly higher initial pv (1.40±0.18 mPa s; p<0.0001) when compared to patients not dying of cancer (1.30±0.10 mPa s). In multivariate proportional hazard regression analysis, next to tumor size (p=0.03) and nodal status (p=0.004), pv was found an independent prognostic marker for overall survival of breast cancer patients (RR=130.2; 95% CI: 11.6–1,460.6; p<0.0001). An optimized preoperative cut‐off value above 1.40 mPa s was significantly associated with poor outcome (log‐rank‐test) in the Kaplan–Meier survival‐estimates, even in node‐negative breast cancer (n=153; 54.6%). The most likely explanation for these findings is that increased fibrinogen/fibrin turnover and breakdown products characteristically associated with tumor‐cell dissemination contribute to the increased plasma viscosity while the hematocrit, leukocyte count, and platelet count contributed little to the increased blood viscosity in patients with breast cancer. These findings may constitute an approach for new strategies in cancer therapy since it might be possible that reduction of plasma viscosity by treatment improves responsiveness to radio/chemotherapy and thus survival of patients.
Journal: Clinical Hemorheology and Microcirculation, vol. 26, no. 1, pp. 55-61, 2002
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl